Insulin therapy in the pediatric intensive care unit

Clinical Nutrition

Volumn 26, Issue 6, 2007, Pages 677-690

  Verbruggen, Sascha C A T ^a,b,c   Joosten, Koen F M ^a   Castillo, Leticia ^b,c   van Goudoever, Johannes B ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c CHILDREN S NUTRITION RESEARCH CENTER   (United States)

Author keywords

Catabolism; Critical illness; Endothelium; Hyperglycemia; Inflammation; Metabolism; Pediatrics

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); REACTIVE OXYGEN METABOLITE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; TRIACYLGLYCEROL; VASCULOTROPIN; VERY LOW DENSITY LIPOPROTEIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; BRAIN INFARCTION; CHILD NUTRITION; CHILDHOOD DISEASE; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; EVIDENCE BASED MEDICINE; FIBRINOLYSIS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMMUNOMODULATION; INNATE IMMUNITY; INSULIN RESISTANCE; INSULIN TREATMENT; INTENSIVE CARE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALNUTRITION; MEDLINE; MORBIDITY; MORTALITY; MYOPATHY; NONHUMAN; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PEDIATRICS; PROTEIN SYNTHESIS; REVIEW; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM; WEIGHT REDUCTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; EVIDENCE-BASED MEDICINE; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; INTENSIVE CARE UNITS, PEDIATRIC; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 36048943947     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2007.08.012     Document Type: Review

References (153)

1. Biolo G., Toigo G., Ciocchi B., et al. Metabolic response to injury and sepsis: changes in protein metabolism. Nutrition 13 (1997) 52S-57S
2. Cogo P.E., Carnielli V.P., Rosso F., et al. Protein turnover, lipolysis, and endogenous hormonal secretion in critically ill children. Crit Care Med 30 (2002) 65-70
3. Klein G.W., Hojsak J.M., and Rapaport R. Hyperglycemia in the pediatric intensive care unit. Curr Opin Clin Nutr Metab Care 10 (2007) 187-192
4. Mizock B.A. Metabolic derangements in sepsis and septic shock. Crit Care Clin 16 (2000) 319-336 vii
5. Anonymous. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 15 (2001) 533-551
6. Montori V.M., Bistrian B.R., and McMahon M.M. Hyperglycemia in acutely ill patients. J Am Med Assoc 288 (2002) 2167-2169
7. van Leeuwen H.J., Heezius E.C., Dallinga G.M., van Strijp J.A., Verhoef J., and van Kessel K.P. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 31 (2003) 1359-1366
8. Wolfe R.R., and Martini W.Z. Changes in intermediary metabolism in severe surgical illness. World J Surg 24 (2000) 639-647
9. Gore D.C., Chinkes D., Heggers J., Herndon D.N., Wolf S.E., and Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 51 (2001) 540-544
10. Preiser J.C., Devos P., and Van den Berghe G. Tight control of glycaemia in critically ill patients. Curr Opin Clin Nutr Metab Care 5 (2002) 533-537
11. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
12. Branco R.G., Garcia P.C., Piva J.P., Casartelli C.H., Seibel V., and Tasker R.C. Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med 6 (2005) 470-472
13. Cochran A., Scaife E.R., Hansen K.W., and Downey E.C. Hyperglycemia and outcomes from pediatric traumatic brain injury. J Trauma 55 (2003) 1035-1038
14. Faustino E.V., and Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 146 (2005) 30-34
15. Srinivasan V., Spinella P.C., Drott H.R., Roth C.L., Helfaer M.A., and Nadkarni V. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 5 (2004) 329-336
16. Wintergerst K.A., Buckingham B., Gandrud L., Wong B.J., Kache S., and Wilson D.M. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 118 (2006) 173-179
17. Yates A.R., Dyke II P.C., Taeed R., et al. Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient. Pediatr Crit Care Med 7 (2006) 351-355
18. Alaedeen D.I., Walsh M.C., and Chwals W.J. Total parenteral nutrition-associated hyperglycemia correlates with prolonged mechanical ventilation and hospital stay in septic infants. J Pediatr Surg 41 (2006) 239-244 discussion 239-44
19. Hall N.J., Peters M., Eaton S., and Pierro A. Hyperglycemia is associated with increased morbidity and mortality rates in neonates with necrotizing enterocolitis. J Pediatr Surg 39 (2004) 898-901 discussion 898-901
20. Pham T.N., Warren A.J., Phan H.H., Molitor F., Greenhalgh D.G., and Palmieri T.L. Impact of tight glycemic control in severely burned children. J Trauma 59 (2005) 1148-1154
21. Binder N.D., Raschko P.K., Benda G.I., and Reynolds J.W. Insulin infusion with parenteral nutrition in extremely low birth weight infants with hyperglycemia. J Pediatr 114 (1989) 273-280
22. Collins Jr. J.W., Hoppe M., Brown K., Edidin D.V., Padbury J., and Ogata E.S. A controlled trial of insulin infusion and parenteral nutrition in extremely low birth weight infants with glucose intolerance. J Pediatr 118 (1991) 921-927
23. Meetze W., Bowsher R., Compton J., and Moorehead H. Hyperglycemia in extremely-low-birth-weight infants. Biol Neonate 74 (1998) 214-221
24. Ng S.M., May J.E., and Emmerson A.J. Continuous insulin infusion in hyperglycaemic extremely-low-birth-weight neonates. Biol Neonate 87 (2005) 269-272
25. Thabet F., Bourgeois J., Guy B., and Putet G. Continuous insulin infusion in hyperglycaemic very-low-birth-weight infants receiving parenteral nutrition. Clin Nutr 22 (2003) 545-547
26. Vaucher Y.E., Walson P.D., and Morrow III G. Continuous insulin infusion in hyperglycemic, very low birth weight infants. J Pediatr Gastroenterol Nutr 1 (1982) 211-217
27. Soghier L.M., Vega M., Aref K., et al. Diffuse basal ganglia or thalamus hyperechogenicity in preterm infants. J Perinatol 26 (2006) 230-236
28. Finney S.J., Zekveld C., Elia A., and Evans T.W. Glucose control and mortality in critically ill patients. J Am Med Assoc 290 (2003) 2041-2047
29. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
30. Van den Berghe G., Wilmer A., Milants I., et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55 (2006) 3151-3159
31. Vriesendorp T.M., DeVries J.H., van Santen S., et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 34 (2006) 2714-2718
32. Joosten K.F., de Kleijn E.D., Westerterp M., et al. Endocrine and metabolic responses in children with meningoccocal sepsis: striking differences between survivors and nonsurvivors. J Clin Endocrinol Metab 85 (2000) 3746-3753
33. van Waardenburg D.A., Jansen T.C., Vos G.D., and Buurman W.A. Hyperglycemia in children with meningococcal sepsis and septic shock: the relation between plasma levels of insulin and inflammatory mediators. J Clin Endocrinol Metab 91 (2006) 3916-3921
34. Koletzko B., Goulet O., Hunt J., Krohn K., and Shamir R. 1. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 41 Suppl 2 (2005) S1-S87
35. Sheridan R.L., Yu Y.M., Prelack K., Young V.R., Burke J.F., and Tompkins R.G. Maximal parenteral glucose oxidation in hypermetabolic young children: a stable isotope study. J Parenter Enteral Nutr 22 (1998) 212-216
36. Donmoyer C.M., Chen S.S., Lacy D.B., et al. Infection impairs insulin-dependent hepatic glucose uptake during total parenteral nutrition. Am J Physiol Endocrinol Metab 284 (2003) E574-E582
37. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?. J Clin Invest 114 (2004) 1187-1195
38. Andreelli F., Jacquier D., and Troy S. Molecular aspects of insulin therapy in critically ill patients. Curr Opin Clin Nutr Metab Care 9 (2006) 124-130
39. Mesotten D., Delhanty P.J., Vanderhoydonc F., et al. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 87 (2002) 5516-5523
40. Mesotten D., Swinnen J.V., Vanderhoydonc F., Wouters P.J., and Van den Berghe G. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 89 (2004) 219-226
41. Vanhorebeek I., De Vos R., Mesotten D., Wouters P.J., De Wolf-Peeters C., and Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365 (2005) 53-59
42. Brealey D., Brand M., Hargreaves I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 (2002) 219-223
43. Ellger B., Debaveye Y., Vanhorebeek I., et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 55 (2006) 1096-1105
44. Van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31 (2003) 359-366
45. Vanhorebeek I., Langouche L., and Van den Berghe G. Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness?. Curr Opin Crit Care 11 (2005) 304-311
46. Van den Berghe G., Schoonheydt K., Becx P., Bruyninckx F., and Wouters P.J. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64 (2005) 1348-1353
47. Carcillo J.A. What's new in pediatric intensive care. Crit Care Med 34 (2006) S183-S190
48. Goldhill D.R., and Sumner A. Outcome of intensive care patients in a group of British intensive care units. Crit Care Med 26 (1998) 1337-1345
49. Pollack M.M., Patel K.M., and Ruttimann U.E. PRISM III: an updated pediatric risk of mortality score. Crit Care Med 24 (1996) 743-752
50. Ruttimann U.E., Patel K.M., and Pollack M.M. Length of stay and efficiency in pediatric intensive care units. J Pediatr 133 (1998) 79-85
51. Wong D.T., Gomez M., McGuire G.P., and Kavanagh B. Utilization of intensive care unit days in a Canadian medical-surgical intensive care unit. Crit Care Med 27 (1999) 1319-1324
52. Carpentier Y.A., and Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 5 (2002) 153-158
53. Khovidhunkit W., Kim M.S., Memon R.A., et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45 (2004) 1169-1196
54. Khovidhunkit W., Memon R.A., Feingold K.R., and Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 181 Suppl 3 (2000) S462-S472
55. Krogh-Madsen R., Moller K., Dela F., Kronborg G., Jauffred S., and Pedersen B.K. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 286 (2004) E766-E772
56. Wolfe R.R., Shaw J.H., and Durkot M.J. Energy metabolism in trauma and sepsis: the role of fat. Prog Clin Biol Res 111 (1983) 89-109
57. Gui D., Spada P.L., De Gaetano A., and Pacelli F. Hypocholesterolemia and risk of death in the critically ill surgical patient. Intensive Care Med 22 (1996) 790-794
58. Chien J.Y., Jerng J.S., Yu C.J., and Yang P.C. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 33 (2005) 1688-1693
59. Giovannini I., Boldrini G., Chiarla C., Giuliante F., Vellone M., and Nuzzo G. Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients. Intensive Care Med 25 (1999) 748-751
60. Vermont C.L., den Brinker M., Kakeci N., et al. Serum lipids and disease severity in children with severe meningococcal sepsis. Crit Care Med 33 (2005) 1610-1615
61. Tulenko T.N., and Sumner A.E. The physiology of lipoproteins. J Nucl Cardiol 9 (2002) 638-649
62. Gordon B.R., Parker T.S., Levine D.M., et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med 24 (1996) 584-589
63. Lind L., and Lithell H. Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival. Clin Intensive Care 5 (1994) 100-105
64. Jeschke M.G., Klein D., and Herndon D.N. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 239 (2004) 553-560
65. Coss-Bu J.A., Jefferson L.S., Walding D., David Y., Smith E.O., and Klish W.J. Resting energy expenditure and nitrogen balance in critically ill pediatric patients on mechanical ventilation. Nutrition 14 (1998) 649-652
66. Coss-Bu J.A., Klish W.J., Walding D., Stein F., Smith E.O., and Jefferson L.S. Energy metabolism, nitrogen balance, and substrate utilization in critically ill children. Am J Clin Nutr 74 (2001) 664-669
67. Joosten K.F., Verhoeven J.J., and Hazelzet J.A. Energy expenditure and substrate utilization in mechanically ventilated children. Nutrition 15 (1999) 444-448
68. Hulst J.M., van Goudoever J.B., Zimmermann L.J., et al. The effect of cumulative energy and protein deficiency on anthropometric parameters in a pediatric ICU population. Clin Nutr 23 (2004) 1381-1389
69. Jeschke M.G., Barrow R.E., and Herndon D.N. Extended hypermetabolic response of the liver in severely burned pediatric patients. Arch Surg 139 (2004) 641-647
70. Hulst J., Joosten K., Zimmermann L., et al. Malnutrition in critically ill children: from admission to 6 months after discharge. Clin Nutr 23 (2004) 223-232
71. Hulst J.M., Joosten K.F., Tibboel D., and van Goudoever J.B. Causes and consequences of inadequate substrate supply to pediatric ICU patients. Curr Opin Clin Nutr Metab Care 9 (2006) 297-303
72. Pollack M.M., Wiley J.S., and Holbrook P.R. Early nutritional depletion in critically ill children. Crit Care Med 9 (1981) 580-583
73. Pollack M.M., Ruttimann U.E., and Wiley J.S. Nutritional depletions in critically ill children: associations with physiologic instability and increased quantity of care. J Parenter Enteral Nutr 9 (1985) 309-313
74. Hasselgren P.O., and Fischer J.E. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg 233 (2001) 9-17
75. Oosterveld M.J., Van Der Kuip M., De Meer K., De Greef H.J., and Gemke R.J. Energy expenditure and balance following pediatric intensive care unit admission: a longitudinal study of critically ill children. Pediatr Crit Care Med 7 (2006) 147-153
76. Pollack M.M., Wiley J.S., Kanter R., and Holbrook P.R. Malnutrition in critically ill infants and children. J Parenter Enteral Nutr 6 (1982) 20-24
77. Hoffer L.J. Protein and energy provision in critical illness. Am J Clin Nutr 78 (2003) 906-911
78. Hadley J.S., and Hinds C.J. Anabolic strategies in critical illness. Curr Opin Pharmacol 2 (2002) 700-707
79. Thissen J.P. How proinflammatory cytokines may impair growth and cause muscle wasting. Horm Res 67 Suppl 1 (2007) 64-70
80. Vary T.C. Regulation of skeletal muscle protein turnover during sepsis. Curr Opin Clin Nutr Metab Care 1 (1998) 217-224
81. de Groof F., Joosten K.F., Janssen J.A., et al. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors. J Clin Endocrinol Metab 87 (2002) 3118-3124
82. Hulst J.M., van Goudoever J.B., Visser T.J., Tibboel D., and Joosten K.F. Hormone levels in children during the first week of ICU-admission: is there an effect of adequate feeding?. Clin Nutr 25 (2006) 154-162
83. Jeschke MG, Barrow RE, Mlcak RP, Herndon DN. Endogenous anabolic hormones and hypermetabolism: effect of trauma and gender differences. Ann Surg 2005;241:759-67; discussion 767-8.
84. Brismar K., Fernqvist-Forbes E., Wahren J., and Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 79 (1994) 872-878
85. Hermans G., Wilmer A., Meersseman W., et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 175 (2007) 480-489
86. Mesotten D., Wouters P.J., Peeters R.P., et al. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. J Clin Endocrinol Metab 89 (2004) 3105-3113
87. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
88. Wray C.J., Mammen J.M., and Hasselgren P.O. Catabolic response to stress and potential benefits of nutrition support. Nutrition 18 (2002) 971-977
89. Hasselgren P.O., Pedersen P., Sax H.C., Warner B.W., and Fischer J.E. Current concepts of protein turnover and amino acid transport in liver and skeletal muscle during sepsis. Arch Surg 123 (1988) 992-999
90. Vary T.C., and Kimball S.R. Regulation of hepatic protein synthesis in chronic inflammation and sepsis. Am J Physiol 262 (1992) C445-C452
91. Vary T.C., Deiter G., and Lang C.H. Cytokine-triggered decreases in levels of phosphorylated eukaryotic initiation factor 4G in skeletal muscle during sepsis. Shock 26 (2006) 631-636
92. Vary T.C., Deiter G., and Kimball S.R. Phosphorylation of eukaryotic initiation factor eIF2Bepsilon in skeletal muscle during sepsis. Am J Physiol Endocrinol Metab 283 (2002) E1032-E1039
93. Vary T.C., and Kimball S.R. Effect of sepsis on eIE4E availability in skeletal muscle. Am J Physiol Endocrinol Metab 279 (2000) E1178-E1184
94. Fujita S., Rasmussen B.B., Cadenas J.G., Grady J.J., and Volpi E. Effect of insulin on human skeletal muscle protein synthesis is modulated by insulin-induced changes in muscle blood flow and amino acid availability. Am J Physiol Endocrinol Metab 291 (2006) E745-E754
95. Bell J.A., Fujita S., Volpi E., Cadenas J.G., and Rasmussen B.B. Short-term insulin and nutritional energy provision do not stimulate muscle protein synthesis if blood amino acid availability decreases. Am J Physiol Endocrinol Metab 289 (2005) E999-E1006
96. Volpi E., Kobayashi H., Sheffield-Moore M., Mittendorfer B., and Wolfe R.R. Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. Am J Clin Nutr 78 (2003) 250-258
97. Wolfe R.R. Effects of insulin on muscle tissue. Curr Opin Clin Nutr Metab Care 3 (2000) 67-71
98. Volpi E., Mittendorfer B., Rasmussen B.B., and Wolfe R.R. The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol Metab 85 (2000) 4481-4490
99. Wray-Cahen D., Beckett P.R., Nguyen H.V., and Davis T.A. Insulin-stimulated amino acid utilization during glucose and amino acid clamps decreases with development. Am J Physiol 273 (1997) E305-E314
100. Wray-Cahen D., Nguyen H.V., Burrin D.G., et al. Response of skeletal muscle protein synthesis to insulin in suckling pigs decreases with development. Am J Physiol 275 (1998) E602-E609
101. Vary T.C., Jefferson L.S., and Kimball S.R. Insulin fails to stimulate muscle protein synthesis in sepsis despite unimpaired signaling to 4E-BP1 and S6K1. Am J Physiol Endocrinol Metab 281 (2001) E1045-E1053
102. Hasselgren P.O., and Fischer J.E. Regulation by insulin of muscle protein metabolism during sepsis and other catabolic conditions. Nutrition 8 (1992) 434-439
103. Gore D.C., Chinkes D.L., Hart D.W., Wolf S.E., Herndon D.N., and Sanford A.P. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med 30 (2002) 2438-2442
104. Gore D.C., Wolf S.E., Herndon D.N., and Wolfe R.R. Relative influence of glucose and insulin on peripheral amino acid metabolism in severely burned patients. J Parenter Enteral Nutr 26 (2002) 271-277
105. Gore D.C., Wolf S.E., Sanford A.P., Herndon D.N., and Wolfe R.R. Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. Am J Physiol Endocrinol Metab 286 (2004) E529-E534
106. Sakurai Y., Aarsland A., Herndon D.N., et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg 222 (1995) 283-297
107. Thomas S.J., Morimoto K., Herndon D.N., et al. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 132 (2002) 341-347
108. Hart DW, Wolf SE, Chinkes DL, et al. Effects of early excision and aggressive enteral feeding on hypermetabolism, catabolism, and sepsis after severe burn. J Trauma 2003;54:755-61; discussion 761-4.
109. Wu X., Thomas S.J., Herndon D.N., Sanford A.P., and Wolf S.E. Insulin decreases hepatic acute phase protein levels in severely burned children. Surgery 135 (2004) 196-202
110. Jeschke M.G., Einspanier R., Klein D., and Jauch K.W. Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 8 (2002) 443-450
111. O'Connor P.M., Bush J.A., Suryawan A., Nguyen H.V., and Davis T.A. Insulin and amino acids independently stimulate skeletal muscle protein synthesis in neonatal pigs. Am J Physiol Endocrinol Metab 284 (2003) E110-E119
112. O'Connor P.M., Kimball S.R., Suryawan A., et al. Regulation of translation initiation by insulin and amino acids in skeletal muscle of neonatal pigs. Am J Physiol Endocrinol Metab 285 (2003) E40-E53
113. Orellana R.A., Kimball S.R., Nguyen H.V., et al. Regulation of muscle protein synthesis in neonatal pigs during prolonged endotoxemia. Pediatr Res 55 (2004) 442-449
114. Orellana R.A., O'Connor P.M., Nguyen H.V., et al. Endotoxemia reduces skeletal muscle protein synthesis in neonates. Am J Physiol Endocrinol Metab 283 (2002) E909-E916
115. Kimball S.R., Orellana R.A., O'Connor P.M., et al. Endotoxin induces differential regulation of mTOR-dependent signaling in skeletal muscle and liver of neonatal pigs. Am J Physiol Endocrinol Metab 285 (2003) E637-E644
116. Orellana R.A., Kimball S.R., Suryawan A., et al. Insulin stimulates muscle protein synthesis in neonates during endotoxemia despite repression of translation initiation. Am J Physiol Endocrinol Metab 292 (2007) E629-E636
117. Orellana R.A., O'Connor P.M., Bush J.A., et al. Modulation of muscle protein synthesis by insulin is maintained during neonatal endotoxemia. Am J Physiol Endocrinol Metab 291 (2006) E159-E166
118. Lang C.H., and Frost R.A. Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha. Metabolism 56 (2007) 49-57
119. O'Connor P.M., Kimball S.R., Suryawan A., et al. Regulation of neonatal liver protein synthesis by insulin and amino acids in pigs. Am J Physiol Endocrinol Metab 286 (2004) E994-E1003
120. Jeschke M.G., Rensing H., Klein D., et al. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol 42 (2005) 870-879
121. Poindexter B.B., Karn C.A., and Denne S.C. Exogenous insulin reduces proteolysis and protein synthesis in extremely low birth weight infants. J Pediatr 132 (1998) 948-953
122. Agus M.S., Javid P.J., Piper H.G., et al. The effect of insulin infusion upon protein metabolism in neonates on extracorporeal life support. Ann Surg 244 (2006) 536-544
123. Agus M.S., Javid P.J., Ryan D.P., and Jaksic T. Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation. J Pediatr Surg 39 (2004) 839-844 discussion 839-44
124. Weekers F., Giulietti A.P., Michalaki M., et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144 (2003) 5329-5338
125. Turina M., Fry D.E., and Polk Jr. H.C. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 33 (2005) 1624-1633
126. Dandona P. The link between insulin resistance syndrome and inflammatory markers. Endocr Pract 9 Suppl 2 (2003) 53-57
127. Dandona P., Aljada A., Dhindsa S., and Garg R. Insulin as an anti-inflammatory and antiatherosclerotic hormone. Clin Cornerstone Suppl 4 (2003) S13-S20
128. Turina M., Miller F.N., Tucker C., and Polk H.C. Effects of hyperglycemia, hyperinsulinemia, and hyperosmolarity on neutrophil apoptosis. Surg Infect (Larchmt) 7 (2006) 111-121
129. Su F., Wang Z., Bruhn A., Verdant C., Cai Y., and Vincent J.L. Euglycemic hyperinsulinemia in severe sepsis and septic shock. Eur Surg Res 38 (2006) 495-502
130. Jeschke M.G., Klein D., Bolder U., and Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145 (2004) 4084-4093
131. Soop M., Duxbury H., Agwunobi A.O., et al. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am J Physiol Endocrinol Metab 282 (2002) E1276-E1285
132. Hansen T.K., Thiel S., Wouters P.J., Christiansen J.S., and Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88 (2003) 1082-1088
133. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101 (2003) 3765-3777
134. Vallet B. Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?. Crit Care 7 (2003) 130-138
135. Anonymous. Endothelial cell dysfunction and abnormal tissue perfusion. Crit Care Med 30 (2002) S229-S234
136. Vallet B., and Wiel E. Endothelial cell dysfunction and coagulation. Crit Care Med 29 (2001) S36-S41
137. Cersosimo E., and DeFronzo R.A. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev 22 (2006) 423-436
138. Langouche L., Vanhorebeek I., Vlasselaers D., et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115 (2005) 2277-2286
139. Nijveldt R.J., Teerlink T., Van Der Hoven B., et al. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 22 (2003) 23-30
140. Nijveldt R.J., Teerlink T., and van Leeuwen P.A. The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis. Clin Nutr 22 (2003) 99-104
141. Stuhlinger M.C., Abbasi F., Chu J.W., et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. J Am Med Assoc 287 (2002) 1420-1426
142. Siroen M.P., Teerlink T., Nijveldt R.J., Prins H.A., Richir M.C., and van Leeuwen P.A. The clinical significance of asymmetric dimethylarginine. Annu Rev Nutr 26 (2006) 203-228
143. Nijveldt R.J., Teerlink T., Siroen M.P., van Lambalgen A.A., Rauwerda J.A., and van Leeuwen P.A. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr 22 (2003) 17-22
144. Aljada A., and Dandona P. Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism 49 (2000) 147-150
145. Siroen M.P., van Leeuwen P.A., Nijveldt R.J., Teerlink T., Wouters P.J., and Van den Berghe G. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?. Crit Care Med 33 (2005) 504-510
146. Dandona P., Mohanty P., Chaudhuri A., Garg R., and Aljada A. Insulin infusion in acute illness. J Clin Invest 115 (2005) 2069-2072
147. Dandona P., Aljada A., Mohanty P., et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. J Clin Endocrinol Metab 86 (2001) 3257-3265
148. Dandona P., and Aljada A. Advances in diabetes for the millennium: diabetes and the endothelium. MedGenMed 6 (2004) 6
149. Aljada A., Ghanim H., Mohanty P., Kapur N., and Dandona P. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 87 (2002) 1419-1422
150. Pomilio M., Mohn A., Verrotti A., and Chiarelli F. Endothelial dysfunction in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 15 (2002) 343-361
151. Erciyas F., Taneli F., Arslan B., and Uslu Y. Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus. Arch Med Res 35 (2004) 134-140
152. Seckin D., Ilhan N., Ilhan N., and Ertugrul S. Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1 diabetes mellitus. Diabetes Res Clin Pract 73 (2006) 191-197
153. Varvarovska J., Racek J., Stetina R., et al. Aspects of oxidative stress in children with type 1 diabetes mellitus. Biomed Pharmacother 58 (2004) 539-545